Guardian Pharmacy Services, Inc. (GRDN) Earnings History
Elite Compounder8 years of earnings data (2018–2025) · 5-year EPS CAGR exceeds 18% — top-tier earnings quality
Loading earnings history...
Guardian Pharmacy Services, Inc. (GRDN) Earnings Overview
As of June 22, 2026, Guardian Pharmacy Services, Inc. (GRDN) reported trailing twelve-month net income of $53M, reflecting +144.1% year-over-year growth. The company earned $0.83 per diluted share over the past four quarters, with a net profit margin of 3.4%.
Looking at the long-term picture, GRDN's 5-year EPS compound annual growth rate (CAGR) stands at +18.8%, indicating exceptional earnings growth. The company achieved its highest annual net income of $49M in fiscal 2025, representing a new all-time high.
Guardian Pharmacy Services, Inc. maintains positive profitability with a gross margin of 19.5%, operating margin of 6.1%, and net margin of 3.4%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including OMCL ($20M net income, 0.2% margin), PINC (-$24M net income, 2.0% margin), CVS ($2.93B net income, 0.4% margin), GRDN has outperformed on profitability metrics. Compare GRDN vs OMCL →
GRDN Earnings vs Peers
Earnings metrics vs comparable public companies
GRDN Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $49M | +156.4% | $89M | $0.78 | 3.4% | 6.1% |
| 2024 | -$87M | -465.2% | -$63M | $-1.77 | -7.1% | -5.1% |
| 2023 | $24M | -32.5% | $41M | $0.39 | 2.3% | 3.9% |
| 2022 | $35M | +117.1% | $52M | $0.58 | 3.9% | 5.7% |
| 2021 | $16M | -18.2% | $30M | $0.27 | 2.1% | 3.8% |
| 2020 | $20M | -8.3% | $32M | $0.33 | 2.7% | 4.4% |
| 2019 | $22M | +48.1% | $34M | $0.36 | 3.1% | 4.9% |
| 2018 | $15M | - | $26M | $0.24 | 2.4% | 4.3% |
Download Data
Export GRDN earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
GRDN — Frequently Asked Questions
Quick answers to the most common questions about buying GRDN stock.
What is GRDN earnings per share (EPS)?
GRDN trailing twelve-month (TTM) diluted EPS is $0.83, reflecting +144.1% year-over-year growth. The 5-year EPS CAGR is +18.8%. Complete EPS history from 2018 to 2025 is available in the table on this page.
What is Guardian Pharmacy Services, Inc.'s net income?
Guardian Pharmacy Services, Inc. (GRDN) trailing twelve-month net income is $53M as of 2025. Earnings grew +144.1% year-over-year.
Is GRDN profitable?
Yes, GRDN is profitable with a TTM net income of $53M and a net profit margin of +3.4%.
What is GRDN's earnings growth rate?
GRDN compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: +10.4%, 5-Year: +18.8%, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2018 to 2025.
What are GRDN's profit margins?
Guardian Pharmacy Services, Inc. net profit margin is +3.4%, operating margin is +6.1%, and gross margin is +19.5%. Below-average margins reflect competitive or cost pressures. Return on Equity is +26.8%.
Is GRDN growing earnings?
Yes, GRDN earnings are accelerating — EPS growth of +144.1% exceeds the 5-year CAGR of +18.8%. TTM net income reached $53M. Earnings momentum is strengthening.
What was GRDN's best earnings year?
Guardian Pharmacy Services, Inc.'s highest annual net income on record is $49M, achieved in fiscal year 2025. Earnings history on this page spans 2018 to 2025 and includes all annual and quarterly figures.
What were GRDN's earnings last quarter?
GRDN's most recent reported quarter was Q1 2026. Net income was $13M with diluted EPS of $0.21. For a full breakdown of all quarters, see the quarterly earnings table on this page.